Mineralocorticoid Antagonism and Diabetic Kidney Disease
Yuliya Lytvyn(University Health Network), David Z.I. Cherney(University Health Network), Rosalie A. Scholtes, Lucas C. Godoy(University of Toronto), Daniël H. van Raalte(Amsterdam University Medical Centers)
Cited by 49
Related Papers
Impact of diabetes on the effects of sodium glucose co-transporter-2 inhibitors on kidney outcomes: collaborative meta-analysis of large placebo-controlled trials
|The Lancet|2022|1k
Depicting the composition of gut microbiota in a population with varied ethnic origins but shared geography
|Nature Medicine|2018|750
Sodium Glucose Cotransporter-2 Inhibition in Heart Failure
|Circulation|2017|470
Association of Adverse Childhood Experiences With Cardiovascular Disease Later in Life
|JAMA Cardiology|2020|248